CATEGORIES

Press Release

LATEST

TRENDING

EDITORS CHOICE

Stroke and Altered Mental State Increase Risk of Death for COVID-19 Patients

People hospitalized with COVID-19 and neurological problems including stroke and confusion, have a higher risk of dying than other COVID-19 patients

Hepion Pharmaceuticals’ CRV431 Demonstrates Efficacy in Kidney Fibrosis

CRV431 has exerted antifibrotic activity in a number of in vitro and in vivo studies conducted by independent research laboratories

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

First Hospitals in U.S. Implant Next-gen Cardiac Device to Reduce Stroke Risk

The WATCHMAN FLX is the only FDA-approved device for the reduction of stroke risk in patients with non-valvular atrial fibrillation (A Fib).